Yancheng Li

Yancheng Li

Auto-generated profile, based on publicly available information

Yancheng Li

Department of Epidemiology, University of Florida

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in JMIR Research Protocols
Verified
Journal Article
Open access
AAAngel B Algarin
Angel B Algarin
GPGabriela N Plazarte
Gabriela N Plazarte
KSKaitlin R Sovich
Kaitlin R Sovich
SSStella D Seeger
Stella D Seeger
YLYancheng Li
Yancheng Li
RCRobert L Cook
Robert L Cook
Background: Marijuana use is common in persons with HIV, but there is limited evidence of its relationship with potential health benefits or harms. Objective: The Marijuana Associated Planning and Long-term Effects (MAPLE) study was designed to evaluate the impact of marijuana use on HIV-related health outcomes, cognitive function, and systemic inflammation. Methods: The MAPLE study is a longitudinal cohort study of participants living with HIV who were recruited from 3 locations in Florida and were either current marijuana users or never regular marijuana users. At enrollment, participants completed questionnaires that included detailed marijuana use assessments, underwent interviewer-administered neurocognitive assessments, and provided blood and urine samples. Ongoing follow-ups included brief telephone assessments (every 3 months), detailed questionnaires (annually), repeated blood and urine samples (2 years), and linkage to medical records and statewide HIV surveillance data. Supplemental measures related to intracellular RNA, COVID-19, Alzheimer disease, and the gut microbiome were added after study initiation. Results: The MAPLE study completed enrollment of 333 persons between 2018 and 2021. The majority of participants in the sample were ≥50 years of age (200/333, 60.1%), male (181/333, 54.4%), cisgender men (173/329, 52.6%), non-Hispanic Black (221/333, 66.4%), and self-reported marijuana users (260/333, 78.1%). Participant follow-up was completed in 2022, with annual updates to HIV surveillance data through at least 2027. Conclusions: The MAPLE study is the largest cohort specifically designed to understand the use of marijuana and its effects on HIV-related outcomes. The study population has significant diversity across age, sex, gender, and race. The data will help clinicians and public health officials to better understand patterns of marijuana use associated with both positive and negative health outcomes, and may inform recommendations for future clinical trials related to medical marijuana and HIV. International Registered Report Identifier (IRRID): DERR1-10.2196/37153

26 November 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
XKXiang-Wei Kong
Xiang-Wei Kong
GBGuolong Bu
Guolong Bu
HCHua Chen
Hua Chen
YHYuhua Huang
Yuhua Huang
ZLZhiwei Liu
Zhiwei Liu
MZMusheng Zeng
Musheng Zeng
BACKGROUND: EBV is associated with nasopharyngeal carcinoma (NPC), but the existence of a NPC protective antibody against EBV-associated antigens remains unclear. METHODS: Patients with NPC and matched controls were identified from prospective cohorts comprising 75,481 participants in southern China. ELISA and conditional logistic regression were applied to assess the effects of gp42-IgG on NPC. The expression of HLA-II, the gp42 receptor, in nasopharyngeal atypical dysplasia and its effect on EBV infection of epithelial cells were evaluated. FINDINGS: gp42-IgG titers were significantly lower in patients with NPC compared with controls across various follow-up years before NPC diagnosis ( P < 0.05). Individuals in the highest quartile for gp42-IgG titers had a 71% NPC risk reduction compared with those in the lowest quartile (ORs Q4vsQ1 = 0.29, 95% CIs = 0·15 to 0.55, P < 0.001). Each unit antibody titer increase was associated with a 34% lower risk of NPC (OR = 0.66, 95% CI = 0.54–0.81, P trend < 0.001). The protective effect of of gp42-IgG was observed in patients diagnosed 5 years or more, 1–5 years, and less than 1 year after blood collection ( P < 0.05). HLA-II expression was detected in 13 of 27 specimens of nasopharyngeal atypical dysplasia, and its overexpression substantially promoted epithelial cell–origin EBV infection. CONCLUSION: Elevated EBV gp42-IgG titers can reduce NPC risk, indicating that gp42 is a potential EBV prophylactic vaccine target. TRIAL REGISTRATION: NCT00941538, NCT02501980, ChiCTR2000028776, ChiCTR2100041628. FUNDING: Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0501003), National Natural Science Foundation of China (82030046, 82073625, 81860601, 82373655), Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2019BT02Y198), and Central Financial Transfer Payment Projects of the Chinese Government, Cancer Research Grant of Zhongshan City.


3 June 2024 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
MBMark K. Britton
Mark K. Britton
JDJason DeFelice
Jason DeFelice
EPEric C. Porges
Eric C. Porges
RCRonald Cohen
Ronald Cohen
YLYancheng Li
Yancheng Li
RCRobert L. Cook
Robert L. Cook

29 July 2025 in Journal of the Association of Nurses in AIDS Care
Verified
Journal Article
Closed access
GIGladys E. Ibañez
Gladys E. Ibañez
SAShyfuddin Ahmed
Shyfuddin Ahmed
AAAngel B. Algarin
Angel B. Algarin
ENEkpereka S. Nawfal
Ekpereka S. Nawfal
YLYancheng Li
Yancheng Li
RCRobert L. Cook
Robert L. Cook
HIV-related enacted stigma refers to experiencing discrimination because of one's HIV status and may be related to sleep disturbance. Using the Florida prospective cohort study ( n = 569), this study examines the direct association between enacted stigma and sleep disturbance and the indirect association between enacted stigma and sleep disturbance via anxiety. Data on stigma and anxiety were collected using self-report surveys at baseline and sleep disturbance at 6 months. Mediation analysis was conducted using structural equation modeling. Most participants were male (58.9%) and non-Hispanic Black (57.2%). Our findings suggested that anxiety fully mediated the association between enacted stigma and sleep disturbance (indirect effect: β = 0.11, 95% confidence interval [CI]: 0.05 to 0.18, p < .001; direct effect: β = 0.06, 95% CI: −0.07 to 0.19, p = .361; total estimated effect: β = 0.18, 95% CI: 0.03 to 0.32, p < .016). Reducing HIV-enacted stigma may improve anxiety and sleep disturbance among people with HIV.

31 July 2026 in AIDS Care
Verified
Journal Article
Closed access
NSNanyangwe Siuluta
Nanyangwe Siuluta
CDCaroline Deaterly
Caroline Deaterly
KVKarina Villalba
Karina Villalba
NSNichole M. Scaglione
Nichole M. Scaglione
YLYancheng Li
Yancheng Li
RCRobert L. Cook
Robert L. Cook
Cervical cancer (CC) is the fourth most common cancer in women and the fourth leading cause of cancer-related mortality in women, accounting for approximately 604,000 new cases and 342,000 deaths g...